Yan, CG, Wang, ZH, Han, LKM, Alexander, N, Alnæs, D, Basgöze, Z, Bauduin, SEEC, Bauer, J, Benedetti, F, Berger, K, Besteher, B, Borgers, T, Bülow, R, Cao, LP, Chen, GM, Chen, JS, Chen, SC, Chen, T, Chen, TL, Chen, X, Chen, YR, Cheng, YQ, Chu, ZS, Colle, R, Connolly, CG, Corruble, E, Couvy-Duchesne, B, Cui, XL, Cullen, KR, Dannlowski, U, Davey, C, Dima, D, Dols, A, Erwin-Grabner, T, Evans, JW, Flinkenflügel, K, Fu, CHY, Fuentes-Claramonte, P, Gao, QL, Gong, QY, Gönül, AS, Gotlib, IH, Goya-Maldonado, R, Grabe, HJ, Groenewold, N, Grotegerd, D, Guo, WB, Hahn, T, Hall, GB, Hamilton, JP, Harrison, B, Hatton, S, He, CC, Hermesdorf, M, Hickie, IB, Ho, TC, Hu, ZJY, Huang, Q, Jahanshad, N, Jamalabadi, H, Jamieson, A, Ji, XL, Jia, FN, Kamishikiryo, T, Kircher, T, Koopowitz, SM, Kraus, A, Krug, A, Kuang, L, Lagopoulos, J, Lancaster, T, Landro, NI, Leehr, EJ, Li, M, Li, BJ, Li, F, Li, HX, Li, T, Li, XY, Liao, YF, Lin, ZD, Linden, DEJ, Liu, HL, Liu, XY, Liu, ZN, Liu, YS, Long, YC, Lu, JP, Lu, B, MacMaster, FP, Maglanoc, LA, McIntosh, AM, Medland, S, Mehler, DMA, Meinert, S, Mwangi, B, Ojha, A, Okada, G, Oudega, ML, Penninx, BWJH, Poletti, S, Pomarol-Clotet, E, Portella, MJ, Qiu, J, Reneman, L, Rise, HS, Rodriguez-Cano, E, Sacchet, MD, Salvador, R, Schlieper, H, Schrantee, A, Shan, XX, Shinzato, H, Si, TM, Sim, K, Soares, JC, Stein, DJ, Straube, B, Strike, LT, Sun, PF, Thomas-Odenthal, F, Thomopoulos, SI, Thompson, PM, Toenders, Y, Uyar, A, van der Wee, NJA, van der Werff, SJA, Veer, IM, Veltman, DJ, Völzke, H, Wagenmakers, M, Walter, H, Walter, M, Wang, CY, Wang, HL, Wang, HN, Wang, X, Wang, XY, Wang, Y, Wang, YW, Westlye, LT, Whalley, HC, Whittle, S, Winter, NR, Wittfeld, K, Wu, MJ, Wu, XP, Wu, XR, Wu, YK, Wu, CN, Xie, CM, Xie, GR, Xie, P, Xu, XF, Xue, ZP, Yang, TT, Yang, H, Yang, J, Yu, H, Yu, YQ, Yuan, ML, Yuan, YG, Zang, YF, Zarate, CA, Zhang, AX, Zhang, KR, Zhang, W, Zhao, JP, Zhong, WY, Zhu, JJ, Zunta-Soares, GB, Zuo, XN, Pozzi, E, Schmaal, L. Vertex-wise cortical abnormalities in major depressive disorder from 64 cohorts from the DIRECT and ENIGMA MDD consortia. Nature Mental Health. 2026; 4(7)DOI:10.1038/s44220-026-00667-9. PMID:. IF:(Q/D).

Barcia, RE, Colón, C, Hermida-Ameijeiras, A, López-Valverde, L, Rodrigues, D, Domínguez-González, C, Díaz-Manera, J, Couce, ML, Alvarez, JV. A Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(13)DOI:10.3390/ijms27135726. PMID:42449999. IF:4.900(Q1/3D).

Vinci, D, Febrero, B, García, JIP, Pellino, G. The impact and role of shared decision-making in surgical practice: A systematic review. CIRUGIA ESPANOLA. 2026; 104(7)DOI:10.1016/j.ciresp.2026.800328. PMID:. IF:1.300(Q3/7D).

González, ST, Bujons-Tur, A, Corbetta, JP, Fadil-Iturralde, JL, Smith-Harrison, LI, Tobia-Gonzalez, I, Ruiz, J, Quiroz, Y, Maiolo, A, Contardi, JC, Weller, S, Rosito, T. Functional outcomes of pyeloplasty in children with reduced preoperative renal function: a multicenter study. Actas Urologicas Espanolas. 2026; 50(6)DOI:10.1016/j.acuro.2026.501990. PMID:. IF:1.200(Q3/7D).

Joye, I, Ricardi, U, Scorsetti, M, Alongi, F, Greto, D, Christ, SM, Braam, P, Simek, IM, Secerov-Ermenc, A, Lievens, Y, Jereczek-Fossa, BA, Dirix, P, Stellamans, K, Ramella, S, Peulen, H, Sancho-Pardo, G, Salinas, JR, Sirak, I, Jeene, P, Bral, S, Benavente, S, Hemmatazad, H, Elaut, N, Clementel, E, Oppong, FB, Guckenberger, M, Ost, P. Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohort. RADIOTHERAPY AND ONCOLOGY. 2026; 220DOI:10.1016/j.radonc.2026.111545. PMID:42019680. IF:5.300(Q1/2D).

Tada, Y, Foley, P, Armstrong, AW, Merola, JF, Chang, JS, Fakharzadeh, S, Rampakakis, E, Huang, YH, Puig, L, Langley, RG. Patient-Level Persistence of On-Treatment Remission With Guselkumab: Pooled Results From VOYAGE 1 and VOYAGE 2 Participants With Moderate-to-Severe Plaque Psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; 95(1)DOI:. PMID:. IF:11.800(Q1/1D).

Lebwohl, M, Blauvelt, A, Kartman, CE, Leatherwood, C, Gordon, KB, Sattar, N, Puig, L, Merola, JF, Siu, K, Wang, R, Sun, L, Leung, A, Somani, N, Rueda, MJ, Cardoso, A, Genovese, MC, Armstrong, AW, Strober, B. Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity A Phase 3b Randomized Clinical Trial. JAMA Dermatology. 2026; 162(7)DOI:10.1001/jamadermatol.2026.1753. PMID:42139049. IF:11.000(Q1/1D).

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, Li, HW, Ofori, S, Pawlikowski, J, Adamson, E, Gooderham, M, Garcia, AL, Lebwohl, M, Nash, P. Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease. JOURNAL OF DERMATOLOGY. 2026; 53(7)DOI:10.1111/1346-8138.70314. PMID:42226468. IF:2.700(Q2/4D).